March 26, 2017 6:16 AM ET


Company Overview of KAEL-GemVax Co., Ltd.

Company Overview

KAEL-GemVax Co., Ltd. develops cancer vaccines and anti-inflammation drugs. The products include GV1001, an epitope vaccine to ensure that the immune system encounters a sufficient number of the epitopes against which an immune response is desired, and encounters them in the right way for the desired immune response to actually begin; and novel peptide-based anti-inflammatory therapeutic drugs to provide cures for various inflammatory diseases. KAEL-GemVax Co., Ltd. was formerly known as GemVax Co., Ltd. The company was founded in 2001 and is based in Seongam, South Korea. KAEL-GemVax Co., Ltd. operates as a subsidiary of GemVax & Kael Co., Ltd.

3rd Floor GemVax Tower

146 Unjung-ro



Seongam,  463-440

South Korea

Founded in 2001


82 2 544 6221


82 2 3443 4997

Key Executives for KAEL-GemVax Co., Ltd.

Chief Executive Officer and President
Founder, Chairman, President and CRO
Chief Executive Officer of USA
Age: 77
Senior Vice President
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
 Chunggei Pharmaceutical Co.,Ltd. Asia
ABL Bio, Inc. Asia
AD Biotech. Co., Ltd. Asia
Ajinomoto Genexine Co., Ltd. Asia
Api Meds, Inc. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KAEL-GemVax Co., Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at